Download PDF

Canadian Anaesthetists’ Society Journal

, Volume 33, Issue 5, pp 606–628 | Cite as

Pulmonary hypertension in children: perioperative management

  • Frederick A. Burrows
  • John R. Klinck
  • Marlene Rabinovitch
  • Desmond J. Bohn
Review Article

Conclusion

Acute rises in PAP are increasingly recognised as a cause of deteriorating condition and even death in children with abnormally reactive pulmonary vasculature secondary to CHD. With increased awareness of the problem, we can identify patients at risk preoperatively so that with careful monitoring and management these rises may be prevented or at least kept at reasonable levels.

Key words

hypertension pulmonary: perioperative management 
Download to read the full article text

References

  1. 1.
    Jones ODH, Shore DF, Rigby ML et al. The use of tolazoline hydrochloride as a pulmonary vasodilator in potentially fatal episodes of pulmonary vasoconstriction after cardiac surgery in children. Circulation 1981; 64 (Suppl. II):134–9.Google Scholar
  2. 2.
    Burrows FA, Rabinovitch M. The pulmonary circulation in children with congenital heart disease: morphologic and morphometric consideration. Can Anaesth Soc J 1985; 32:364–73.PubMedGoogle Scholar
  3. 3.
    Sibbald WJ, Drledger AA. Right ventricular function in acute disease states: pathophysiologic considerations. Crit Care Med 1983; 11:339–45.PubMedGoogle Scholar
  4. 4.
    haver MB, Strauss W, Pohost GM. Herbert Shubin Memorial Lecture. Right and left ventricular geometry: adjustments during acute respiratory failure. Crit Care Med 1979; 7:509–19.Google Scholar
  5. 5.
    Vlahakes GJ, Turley K, Hoffman JIE. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 1981; 63:87–95.PubMedGoogle Scholar
  6. 6.
    Perkin RM, Anas NC. Pulmonary hypertension in pediatric patients. J Pediatr 1984; 105:511–22.PubMedGoogle Scholar
  7. 7.
    Prewitt RM, Ghignone M. Treatment of right ventricular dysfunction in acute respiratory failure. Crit Care Med 1983; 11:346–52.PubMedGoogle Scholar
  8. 8.
    Weber AT, Janicki JS, Shroff SG, Likoff MJ, Sutton MGSU. The right ventricle: physiologic and pathophysiologic considerations. Crit Care Med 1983; 11:323–8.PubMedGoogle Scholar
  9. 9.
    Goldberg HS, Rabson J. Control of cardiac output by systemic vessels. Circulatory adjustments to acute and chronic respiratory failure and the effect of therapeutic interventions. Am J Cardiol 1981; 47:696–702.PubMedGoogle Scholar
  10. 10.
    Thompson IR. Cardiovascular physiology: venous return. Can Anaesth Soc J 1984; 31:S31–7.Google Scholar
  11. 11.
    Donnelly WH, Buciarelli RL, Nelson RM. Ischemic papillary muscle necrosis in stressed newborn infants. J Pediatr 1980; 96:925–300.Google Scholar
  12. 12.
    Stanger P, Lucas PV Jr,Edwards JE. Anatomic factors causing respiratory distress in acyanotic congenital cardiac disease. Special reference to bronchial obstruction. Pediatrics 1969; 43:760–9.PubMedGoogle Scholar
  13. 13.
    Bancalari E, Jesse MJ, Gelband H, Garcia O. Lung mechanics in congenital heart disease with increased and decreased pulmonary blood flow. J Pediatr 1977; 90:192–5.PubMedGoogle Scholar
  14. 14.
    Hordof AJ, Mellins RB, Gersony WM, Steeg CN. Reversibility of chronic obstructive lung disease in infants following repair of ventricular septal defect. J Pediatr 1977; 90:187–91.PubMedGoogle Scholar
  15. 15.
    Fernandez-Bonetti P, Lupi-HerreraE, Martinez-Guerra ML, Barrios R, Seoane M, Sandoval J. Peripheral airways obstruction in idiopathic pulmonary artery hypertension (primary). Chest 1983; 83:732–8.PubMedGoogle Scholar
  16. 16.
    Dantzker DR, Bower JS. Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease. J Clin Invest 1979; 64:1050–5.PubMedGoogle Scholar
  17. 17.
    Macklem PT. Respiratory muscles: the vital pump. Chest 1980; 78:753–8.PubMedGoogle Scholar
  18. 18.
    Nunn JF. Applied Respiratory Physiology, 2nd edition. London: Butterworths, 1977:213–4.Google Scholar
  19. 19.
    Nussbaum E. Adult-type respiratory distress syndrome in children. Clin Pediatr 1983; 22:401–6.Google Scholar
  20. 20.
    Rabinovitch M. Pulmonary Hypertension. In: Adams FH, Emmanouilides GC, eds. Moss Heart Disease in Infants, Children, and Adolescents, 3rd edition. Baltimore: Williams & Wilkins Co., 1983.Google Scholar
  21. 21.
    Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18:533–47.PubMedGoogle Scholar
  22. 22.
    Vogel JH, Grover RF, Blount SG Jr. Progressive pulmonary hypertension in ventricular septal defect. Clin Res 1963; 11:100.Google Scholar
  23. 23.
    Hoffman JIE, Rudolph AM. The natural history of ventricular septal defects in infancy. Am J Cardiol 1965; 16:634–53.PubMedGoogle Scholar
  24. 24.
    Cartmill TB, DuShane JW, McGoon DC, Kirklin JW. Results of repair of ventricular septal defect. J Thorac Cardiovasc Surg 1966; 52:486–501.PubMedGoogle Scholar
  25. 25.
    Hallidie-Smith KA, Hollman A, Cleland WP, Bentall HH, Goodwin JF. Effects of surgical closure of ventricular septal defects upon pulmonary vascular disease. Br Heart J 1969; 31:246–60.PubMedGoogle Scholar
  26. 26.
    DuShaneJW, Krongrad E, Ritter DG, McGoon DC. The fate of raised pulmonary vascular resistance after surgery in ventricular septal defect. In: Kidd BSL, Rowe RD, eds. The Child with Congenital Heart Disease After Surgery. Mount Kisco, NY: Futura Publishing Co., 1976.Google Scholar
  27. 27.
    Kouchoukos NT, Blackstone EH, Kirklin JW.Surgical implications of pulmonary hypertension in congenital heart disease. Adv Cardiol 1978; 22:225–31.PubMedGoogle Scholar
  28. 28.
    Graham TP, Bender HW, Spach MS. Ventricular septal defect. In: Moss’ Heart Disease in Infants, Children, and Adolescents, 3rd edition. Adams FH, Emmanouilides GC, eds. Baltimore: Williams & WilkinsCo., 1983.Google Scholar
  29. 29.
    Rosenthal A, Nathan DG, Marty AT, Button LN, Miettinen OS, Nadas AS. Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation 1970; 42:297–307.PubMedGoogle Scholar
  30. 30.
    Paul MH. Transposition of the great arteries. In: Moss’ Heart Disease in Infants, Children, and Adolescents, 3rd edition. Adams FH, Emmanouilides GC, eds. Baltimore: Williams & Wilkins Co., 1983.Google Scholar
  31. 31.
    Cox MA, Schiebler GL, Taylor WJ, Wheat MW Jr,Krovetz LJ. Reversible pulmonary hypertension in a child with respiratory obstruction and cor pulmonale. J Pediatr 1965; 67:192–7.Google Scholar
  32. 32.
    Noonan JA. Reversible cor pulmonale due to hyper-trophied tonsils and adenoids: studies in two cases. Circulation 1965; 32:11–164 (Abstract).Google Scholar
  33. 33.
    Luke MJ, Mehrizi A, Folger GM Jr,Rowe RD. Chronic nasopharyngeal obstruction as a cause of cardiomegaly, cor pulmonale, and pulmonary edema. Pediatrics 1966; 37:762–8.PubMedGoogle Scholar
  34. 34.
    Levy AM, Tabakin BS, Hanson JS, Narkewicz RM. Hypertrophied adenoids causing pulmonary hypertension and severe congestive heart failure. N Engl J Med 1967; 277:506–11.PubMedGoogle Scholar
  35. 35.
    Jeresaty RM, Huszar RJ, Basu S.Pierre Robin syndrome: cause of respiratory obstruction, cor pulmonale, and pulmonary edema. Am J Dis Child 1969; 117:710–6.PubMedGoogle Scholar
  36. 36.
    Krieger AJ, Rosomoff HL, Kuperman AS, Zingesser LH. Occult respiratory dysfunction in a craniovertebral anomaly. J Neurosurg 1969; 31:15–20.PubMedGoogle Scholar
  37. 37.
    Don N, Siggers DC. Cor pulmonale in Crouzon’s disease. Arch Dis Child 1971; 46:394–6.PubMedGoogle Scholar
  38. 38.
    Cogswell JJ, Easton DM. Cor pulmonale in Pierre Robin syndrome. Arch Dis Child 1974; 49:905–8.PubMedGoogle Scholar
  39. 39.
    Levin DL, Muster AJ, Pachman LM, Wessel HU, Paul MH, Koshaba J. Cor pulmonale secondary to upper airway obstruction. Cardiac catheterization, immunologic, and psychometric evaluation in nine patients. Chest 1975; 68:166–71.PubMedGoogle Scholar
  40. 40.
    Paparo GP, Symchych PS. Postintubation subglottic stenosis and cor pulmonale. J Pediatr 1977; 90:97–8.PubMedGoogle Scholar
  41. 41.
    Robson MC, Stankiewicz JA, Medelsohn JS. Cor pulmonale secondary to cleft palate repair. Plast Reconstr Surg 1977; 59:754–7.PubMedGoogle Scholar
  42. 42.
    Suckerman S, Healy GB. Sleep apnea syndrome associated with upper airway obstruction. Laryngoscope 1979; 89:878–85.Google Scholar
  43. 43.
    Freeman MK, Manners JM. Cor pulmonale and the Pierre Robin anomaly. Airway management with a nasopharyngeal tube. Anaesthesia 1980; 35:282–6.PubMedGoogle Scholar
  44. 44.
    Johnson GM, Todd DW. Cor pulmonale in severe Pierre Robin syndrome. Pediatr 1980; 65:152–4.Google Scholar
  45. 45.
    Mair DD, Edwards WD, Fuster V, Seward JB, Danielson GK. Truncus arteriosus. In: Moss’ Heart Disease in Infants, Children, and Adolescents, 3rd edition. Adams FH, Emmanouilides GC, eds. Baltimore: Williams and Wilkins Co., 1983.Google Scholar
  46. 46.
    Bagshaw RJ, Cox RH. Pulmonary vascular response is dependent upon initial state of the vasculature. Anesthesiology 1983; 58:205–6.PubMedGoogle Scholar
  47. 47.
    Cox RH. Comparison of mechanical and chemical properties of extra- and intralobar canine pulmonary arteries. Am J Physiol 1982; 242:H245-H253.PubMedGoogle Scholar
  48. 48.
    Fishman AP. Hypoxia on the pulmonary circulation: how and where it acts. Circ Res 1976; 38:221–31.PubMedGoogle Scholar
  49. 49.
    Lewis AB, Heymann MA, Rudolph AM. Gestational changes in pulmonary vascular responses in fetal lambs in utero. Circ Res 1976; 39:536–41.PubMedGoogle Scholar
  50. 50.
    Wagenvoort CA, Wagenvoort N. Pathology of pulmonary hypertension. New York: Wiley, 1977.Google Scholar
  51. 51.
    Moss AJ. The cardiovascular system in cystic fibrosis. Pediatrics 1982; 70:728–41.PubMedGoogle Scholar
  52. 52.
    Rudolph AM, Auld PAM, Golinko RJ, Paul MH. Pulmonary vascular adjustments in the neonatal period. Pediatrics 1961; 28:28–34.PubMedGoogle Scholar
  53. 53.
    Caffin S, Dawes GS, Mott JC, Ross BB, Strong BB. The vascular resistance of the fetal and newly ventilated lung of the lamb. J Physiol 1964; 171:61–79.Google Scholar
  54. 54.
    Rudolph AM, Yuan S. Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. J Clin Invest 1966; 45:399–411.PubMedGoogle Scholar
  55. 55.
    Hyman AL, Higashida RT, Spannhake EW, Kadowitz PJ. Pulmonary vasoconstrictor responses to graded decreases in precapillary blood PO2 in intact-chest cats. J Appl Physiol 1981; 51:1009–16.PubMedGoogle Scholar
  56. 56.
    Campbell AGM, Cockburn F, Dawes GS, Milligan JE. Pulmonary vasoconstriction in asphyxia during cross-circulation between twin fetal lambs. J Physiol 1967; 192:111–21.PubMedGoogle Scholar
  57. 57.
    Campbell AGM, Dawes GS, Fishman AP, Hyman AI. Pulmonary vasoconstriction and changes in heart rate during asphyxia in immature fetal lambs. J Physiol 1967; 192:93–110.PubMedGoogle Scholar
  58. 58.
    Silove ED, Grover RF. Effects of alpha adrenergic blockage and tissue catecholamine depletion on pulmonary vascular response to hypoxia. J Clin Invest 1968; 47:274–85.PubMedGoogle Scholar
  59. 59.
    Porcelli RJ, Viau A, Demeny M, Naftchi NE, Bergofsky EH. Relation between hypoxic pulmonary vasoconstriction, its humoral meditors and alphabeta adrenergic receptors. Chest 1977; 71:249–51.PubMedGoogle Scholar
  60. 60.
    Kato M, Staub NC. Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circ Res 1966; 19:426–40.PubMedGoogle Scholar
  61. 61.
    Glazier JB, Murray JF. Sites of pulmonary vasomotor reactivity in the dog during alveolar hypoxia and serotonin and histamine infusion. J Clin Invest 1971; 50:2550–8.PubMedGoogle Scholar
  62. 62.
    Berkov S. Hypoxic pulmonary vasoconstriction in the rat: the necessary role of angiotensin. II. Circ Res 1974; 35:256–61.Google Scholar
  63. 63.
    Lloyd TC Jr. Responses to hypoxia of pulmonary arterial strips in nonaqueous baths. J Appl Physiol 1970; 28:566–9.PubMedGoogle Scholar
  64. 64.
    Hauge A. Role of histamine in hypoxic pulmonary hypertension in the rat. I. Blockade or potentiation of endogenous amines, kinins, and ATP. Circ Res 1968; 22:371–83.PubMedGoogle Scholar
  65. 65.
    Hauge A, Melmon KL. Role of histamine in hypoxic pulmonary hypertension in the rat. II. Depletion of histamine, serotonin, and catecholamines. Circ Res 1968; 22:385–92.PubMedGoogle Scholar
  66. 66.
    Haas F, Bergofsky EH. Role of the mast cell in the pulmonary pressor response to hypoxia. J Clin Invest 1972; 51:3154–62.PubMedGoogle Scholar
  67. 67.
    Tucker A, Weir EK, Reeves JT, Grover RF. Failure of histamine antagonists to prevent hypoxic pulmonary vasoconstriction in dogs. J Appl Physiol 1976; 40:496–500.PubMedGoogle Scholar
  68. 68.
    Peckham GJ, Fox WW. Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertension. J Pediatr 1978; 93:1005–10.PubMedGoogle Scholar
  69. 69.
    Wagner CW, Nesbit RR, Mansberger AR. Treatment of metabolic alkalosis with intravenous hydrochloric acid. S Med J 1979; 72:1241–5.Google Scholar
  70. 70.
    Hodgkin JE, Soeprono FF, Chan DM. Incidence of metabolic alkalemia in hospitalized patients. Crit Care Med 1980; 8:725–8.PubMedGoogle Scholar
  71. 71.
    Drummond WH, Gregory GA, Heymann MA, Phibbs RA. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistant pulmonary hypertension. J Pediatr 1981; 98:603–11.PubMedGoogle Scholar
  72. 72.
    Case RB, Felix A, Wachter M, Kyriakidis G, Castellana F. Relative effect of CO2 on canine coronary vascular resistance. Circ Res 1978; 42:410–8.PubMedGoogle Scholar
  73. 73.
    McBride DC, Wilson JL.Pettett G. Hyperventilation in the treatment of persistent fetal circulation. J Pediatr 1980; 96:174–5.PubMedGoogle Scholar
  74. 74.
    Whittenberger JL, McGregor M, Berglund E, Borst HG. Influence of state of inflation of the lung on pulmonary vascular resistance. J Appl Physiol 1960; 15:878–82.PubMedGoogle Scholar
  75. 75.
    Marshall BE, Wyche MQ Jr. Hypoxemia during and after anesthesia. Anesthesiology 1972; 37:178–209.PubMedGoogle Scholar
  76. 76.
    Slater EM, Nilsson E, Leake DL et al. Arterial oxygen tension measurements during nitrous oxide-oxygen anesthesia. Anesthesiology 1965; 26:642–7.PubMedGoogle Scholar
  77. 77.
    Laws AK. Effects of induction of anaesthesia and muscle paralysis on functional residual capacity of the lungs. Can Anaesth Soc J 1968; 15:325–31.PubMedGoogle Scholar
  78. 78.
    Don HF, Wahba M, Cuadrado L, Kelkar M. The effects of anaesthesia and 100 per cent oxygen on the functional residual capacity of the lungs. Anesthesiology 1970; 32:521–9.PubMedGoogle Scholar
  79. 79.
    Don H, Craig DB, Wahba WM, Couture JG. The measurement of gas trapped in the lungs at functional residual capacity and the effects of posture. Anesthesiology 1971; 35:582–90.PubMedGoogle Scholar
  80. 80.
    Rehder K, Hatch DJ, Sessler AD, Marsh HM, Fowler, WS. Effects of general anaesthesia, muscle paralysis, and mechanical ventilation on pulmonary nitrogen clearance. Anesthesiology 1971; 35:591–601.PubMedGoogle Scholar
  81. 81.
    Hickey RF, Visick WD, Fairley HB, Fourcade HE. Effects of halothane anesthesia on functional resi dual capacity and alveolar-arterial oxygen tension difference. Anesthesiology 1973; 38:20–4.PubMedGoogle Scholar
  82. 82.
    Freund F, Roos A, Dodd RB. Expiratory activity of the abdominal muscles in man during general anesthesia. J Appl Physiol 1964; 19:693–701.PubMedGoogle Scholar
  83. 83.
    Froese AB, Bryan AC. Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology 1974; 41:242–55.PubMedGoogle Scholar
  84. 84.
    Burton AC, Patel DJ. Effect on pulmonary vascular resistance of inflation of the rabbit lungs. J Appl Physiol 1958; 12:239–46.PubMedGoogle Scholar
  85. 85.
    Benumof JL. Mechanisms of decreased blood flow to atelectatic lung. J Appl Physiol 1979; 46:1047–8.PubMedGoogle Scholar
  86. 86.
    Charlier AA. Beat to beat hemodynamic effects of lung inflation and normal respiration in anaesthetized and conscious dogs. Brussels: Presses Academiqius, Euraprennes, 1968.Google Scholar
  87. 87.
    Liebman PR, Patten MT, Manny J, Shepro D, Hechtman HB. The mechanism of depressed cardiac output on positive end-expiratory pressure (PEEP). Surgery 1978; 83:594–8.PubMedGoogle Scholar
  88. 88.
    Manny J, Patten MT, Liebman PR, Hechtman HB. The association of lung distention, PEEP and biventricular failure. Ann Surg 1978; 187:151–7.PubMedGoogle Scholar
  89. 89.
    Jardin F, Farcot JC, Boisante L, Curien N, Margairaz A, Bourdarias JP. Influence of positive end-expiratory pressure on left ventricular performance. N Engl J Med 1981; 304:387–92.PubMedGoogle Scholar
  90. 90.
    Perkin RM, Levin DL. Adverse effects of positivepressure ventilation in children. In: Gregory GA, ed. Respiratory failure in the child. New York: Churchill Livingstone, 1981: 163–187.Google Scholar
  91. 91.
    Andreasen F, Christensen JH. Thiopentone induced changes in the contraction pattern of vascular smooth muscle: the influence of albumin. Br J Pharmacol 1983; 82:643–50.Google Scholar
  92. 92.
    Goldberg SJ, Linde LM, Goal PG et al. Effects of barbiturates on pulmonary and systemic haemodynamics. Cardiovasc Res 1968; 2:136–42.PubMedGoogle Scholar
  93. 93.
    Sørensen MB, Jacobsen E. Pulmonary hemo-dynamics during induction of anesthesia. Anesthesiology 1977; 46:246–51.PubMedGoogle Scholar
  94. 94.
    Dolar D, Sun S. The effects of thiopentone on the pulmonary circulation. In: Cardiovascular Measurement in Anesthesiology. Prys-Roberts C, Vickers MD,eds. New York: Springer-Verlag, 1981:251–5.Google Scholar
  95. 95.
    Tweed WA, Minuck M, Mymin D. Circulatory responses to ketamine anesthesia. Anesthesiology 1972; 37:613–9.PubMedGoogle Scholar
  96. 96.
    Gooding JMD, imick AR, Tavakoli M, Corssen G. A physiologic analysis of cardiopulmonary response to ketamine anesthesia in noncardiac patients. Anesth Analg 1977; 56:813–6.PubMedGoogle Scholar
  97. 97.
    Spotoft H, Korshin JD, Sørensen MB, Skovsted P. The cardiovascular effects of ketamine used for induction of anaesthesia in patients with valvular heart disease. Can Anaesth Soc J 1979; 26:463–7.PubMedGoogle Scholar
  98. 98.
    Tarnow J, Hess W, Schmidt D, Eberlein HJ. Narkoseeinleitung bei patienten mit koronarer Herzkrankheit: Flunitrazepam, Diazepam, Ketamin, Fentanyl. Ein hämodynamische Untersuchung. Anaesthesist 1979; 28:9–19.PubMedGoogle Scholar
  99. 99.
    Morray JP, Lynn AM, Stamm SJ, Herndon PS, Kawabori I, Stevenson JG. Hemodynamic effects of ketamine in children with congenital heart diseases. Anesth Analg 1984; 63:895–9.PubMedGoogle Scholar
  100. 100.
    Hickey PR, Hansen DD, Cramolini GM, Vincent RN, Lang P. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1985; 62:287–93.PubMedGoogle Scholar
  101. 101.
    Bålfors E, Haggmark S, Nyhman H, Rydvall A, Reiz S. Droperidol inhibits the effects of intravenous ketamine on central hemodynamics and myocardial oxygen consumption in patients with generalized. atherosclerotic disease. Anestfi Analg 1983; 62:193–7.Google Scholar
  102. 102.
    de Castro J, Van de Water A, Wouters L, Xhonneux R, Reneman R, Kay B. Comparative study of cardiovascular, neurological and metabolic side effects of 8 narcotics in dogs. Pethidine, piritramide, morphine, phenoperidine, fentanyl, R 39 209, sufentanil, R 34 995. I. Comparative study on the acute toxicity and hemodynamic effects of the narcotics in high and massive doses in curarised and mechanically ventilated gos. Acta Anaesthesiol Belg 1979; 30:5–54.PubMedGoogle Scholar
  103. 103.
    Lappas DG, Geha D, Fischer JE, Laver MB, Lowenstein E. Filling pressures of the heart and pulmonary circulation of the patient with coronary-artery disease after large intravenous doses of morphine. Anesthesiology 1975; 42:153–9.PubMedGoogle Scholar
  104. 104.
    Wynands JE, Wong P, Whalley DG, Sprigge JS, Townsend GE, Patel YC. Oxygen-fentanyl anesthesia in patients with poor left ventricular function: hemodynamics and plasma fentanyl concentration. Anesth Analg 1983; 62:476–82.Google Scholar
  105. 105.
    de Lange S, Boscoe MJ, Stanley TH, Pace N. Comparison of sufentanil-O2 and fentanyl-O2 for coronary artery surgery. Anesthesiology 1982; 56:112–8.PubMedGoogle Scholar
  106. 106.
    Steffey EP, Gillespie JR, Berry JD, Eger EI II,Rhode EA. Cardiovascular effects of halothane in the stump-tailed macaque during spontaneous and controlled ventilation. Am J Vet Res 1974; 35:1315–9.PubMedGoogle Scholar
  107. 107.
    Waller JL, Hug CC.Nagle DM, Craver JM. Hemo-dyamic changes during fentanyl-oxygen anesthesia for aortocoronary bypass operation. Anesthesiology 1982; 55:212–7.Google Scholar
  108. 108.
    Hickey PR, Hansen DD. Fentanyl- and sufentanil-oxygen-pancuronium anesthesia for cardiac surgery in infants. Anesth Analg 1984; 63:117–24.PubMedGoogle Scholar
  109. 109.
    Hickey PR, Hansen DD.Wessel D. Responses to high dose fentanyl in infants: II. Blunting of stress responses in the pulmonary circulation. Anesthesiology 1984; 61:A446.Google Scholar
  110. 110.
    Hickey PR, Hansen DD, Wessel DL, Lang P, Jonas RA. Pulmonary and systemic hemodynamic responses to fentanyl in infants. Anesth Analg 1985; 64:483–6.PubMedGoogle Scholar
  111. 111.
    Holl JE, Kolbeck RC, Speir WA Jr. Pulmonary vascular responsiveness to histamine: exquisite sensitivity of small intrapulmonary arteries. Am Rev RespirDis 1980; 122:909–13.Google Scholar
  112. 112.
    Porcelli RJ, Ventura DF, Mahoney WA, Bergofsky EA. Role of histamine in regulating pulmonary vascular tone and reactivity. J Appl Physiol 1981; 51:1320–5.PubMedGoogle Scholar
  113. 113.
    Bjertnaes LJ. Hypoxia-induced pulmonary vasoconstriction in man: inhibition due to diethyl ether and halothane anesthesia. Acta Anaesthesiol Scand 1978; 22:570–88.PubMedGoogle Scholar
  114. 114.
    Bjertnaes LJ. Intravenous versus inhalation anesthesia - pulmonary effects. Acta Anaesthesiol Scand 1982; 26: (Suppl. 75):18–24.Google Scholar
  115. 115.
    Syke MK, Gibbs JM, Loh L, Marin JBL, Obdrazalek J, Arnot RN. Preservation of the pulmonary vasoconstrictor response to alveolar hypoxia during the administration of halothane to dogs. Br J Anaesth 1978; 50:1185–96.Google Scholar
  116. 116.
    Fargas-Babjak A, Forrest JB. Effect of halothane on the pulmonary vascular response to hypoxia in dogs. Can Anaesth Soc J 1979; 26:4–14.Google Scholar
  117. 117.
    Marshall BE, Hoffman DA, Neufeld GR, Cotton El. Influence of induction agent on pulmonary venous admixture during halothane: oxygen anaesthesia with controlled respiration in man. Can Anaesth Soc J 1974; 21:461–6.PubMedGoogle Scholar
  118. 118.
    Heitz DC, Jebson PJ, Boutros AR, Brady MJ. The effects of halothane on the pulmonary vascular bed of the dog. Anesthesiology 1971; 35:61–7.PubMedGoogle Scholar
  119. 119.
    Ota N. [Studies on vascular impedence. (2) Effects of halothane and hypoxia on pulmonary vascular impedence.] Jpn J Anesthesiol 1977; 26:272–8.Google Scholar
  120. 120.
    Bagshaw RJ, Cox RH. Baroreceptor reflexes and pulmonary hemodynamics during halothane and halothane-nitrous oxide anesthesia in the dog. Anesth Analg 1981; 60:701–9.PubMedGoogle Scholar
  121. 121.
    Dubikaitis AYu, Beliakov NA, Simbirtsev SA. Pulmonary vascular responses to inhalation anaesthesia in isolated dog lungs. Cor Vasa 1980; 22:384–92.PubMedGoogle Scholar
  122. 122.
    Price HL, Cooperman LH, Warden JC, Morriss JJ, Smith TC. Pulmonary hemodynamics during general anesthesia in man. Anesthesiology 1969; 30:629–36.PubMedGoogle Scholar
  123. 123.
    Schulte-Sasse U, Hess W, Tarnow J. Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 1982; 57:9–13.PubMedGoogle Scholar
  124. 124.
    Morr-Strathmann U, Lawin P. The effects of Ethrane on the hemodynamics of the pulmonary circulation. Acta Anesthesiol Belg 1976; 27 (Suppl.):245–9.Google Scholar
  125. 125.
    Philbin DM, Lowenstein E. Hemodynamic consequences of the combination of isoflurane anesthesia (1 MAC) and beta-adrenergic blockade in the dog. Anesthesiology 1975; 42:567–73.PubMedGoogle Scholar
  126. 126.
    Philbin DM, Lowenstein E. Lack of beta-adrenergic activity of isoflurane in the dog: a comparison of circulatory effects of halothane and isoflurane after propranolol administration. Br J Anaesth 1976; 48:1165–70.PubMedGoogle Scholar
  127. 127.
    Horan BF, Prys-Roberts C, Roberts JG, Bennett MJ, Foex P. Haemodynamic responses to isoflurane anaestheisa and hypovolaemia in the dog, and their modification by propranolol. Br J Anaesth 1977; 49:1179–87.PubMedGoogle Scholar
  128. 128.
    Steffey EP.Howland D Jr. Isoflurane potency in the dog and cat. Am J Vet Res 1977; 38:1833–6.PubMedGoogle Scholar
  129. 129.
    Tarnow J, Eberlein JH, Oser G et al. Harnodynamik, Myokardkontraktilitat, Ventrikelvolumina und Sauerstoffversorgung des Herzens unter verschiedenen Inhalationsanaesthetika. Anaesthesist 1977; 26:220–30.PubMedGoogle Scholar
  130. 130.
    Steffey ED, Howland D Jr. Comparison of circulatory and respiratory effects of isoflurane and halo thane anesthesia in horses. Am J Vet Res 1980; 41:821–5.PubMedGoogle Scholar
  131. 131.
    Marshall C, Lindgren L, Marshall BE. Effects of halothane, enflurane, and isoflurane on hypoxic pulmonary vasoconstriction in rat lungs in vitro. Anesthesiology 1984; 60:304–8.PubMedGoogle Scholar
  132. 132.
    Klide AM. Cardiopulmonary effects of enflurane and isoflurane in the dog. Am J Vet Res 1976; 37:127–31.PubMedGoogle Scholar
  133. 133.
    Tarnow J, Bruckner JB, Eberlein HJ, Hess W, Ratschke D. Haemodynamics and myocardial oxygen consumption during isoflurane (Forane) anaesthesia in geriatric patients. Br J Anaesth 1976; 48:669–75.PubMedGoogle Scholar
  134. 134.
    Nicholas JF, Lam AM. Isoflurane-induced hypotension does not cause impairment in pulmonary gas exchange. Can Anaesth Soc J 1984; 31:352–8.PubMedGoogle Scholar
  135. 135.
    Smith NT, Eger EI II,Stoelting RK, Whayne TF, Cullen D, Kadis LB. The cardiovascular and sympathomimetic responses to the addition of nitrous oxide to halothane in man. Anesthesiology 1970; 32:410–21.PubMedGoogle Scholar
  136. 136.
    Eisele JH, Smith NTY. Cardiovascular effects of 40 percent nitrous oxide in man. Anesth Analg 1972; 51:956–61.PubMedGoogle Scholar
  137. 137.
    Stoelting RK, Gibbs PS. Hemodynamic effects of morphine and morphine-nitrous oxide in valvular heart disease and coronary artery disease. Anesthesiology 1973; 38:45–52.PubMedGoogle Scholar
  138. 138.
    Wong KC, Martin WE, Hornbein TF, Freund FG, Everett J. The cardiovascular efects of morphine sulphate with oxygen and with nitrous oxide in man. Anesthesiology 1973; 38:542–9.PubMedGoogle Scholar
  139. 139.
    Lappas DG, Buckley MJ, Lover MB, Daggett WM, Lowenstein E. Left ventricular performance and pulmonary circulation following addition of nitrous oxide to morphine during coronary artery surgery. Anesthesiology 1975; 43:61–9.PubMedGoogle Scholar
  140. 140.
    McDermott RW, Stanley TH. The cardiovascular effects of low concentrations of nitrous oxide during morphine anesthesia. Anesthesiology 1974; 41:89–91.PubMedGoogle Scholar
  141. 141.
    Eisele JH, Reitan JA, Massumi RA, Zelis RF, Miller RR. Myocardial performance and N2O analgesia in coronary artery disease. Anesthesiology 1976; 44:16–20.PubMedGoogle Scholar
  142. 142.
    Lunn JK, Stanley TH, Eisele J, Webster L, Woodward A. High dose fentanyl anesthesia for coronary artery surgery: plasma fentanyl concentrations and influence of nitrous oxide on cardiovascular responses. Anesth Analg 1979; 58:390–5.PubMedGoogle Scholar
  143. 143.
    Hilgenberg JC, McCammon RL, Stoelting RK. Pulmonary and systemic vascular responses to nitrous oxide in patients with mitral stenosis and pulmonary hypertension. Anesth Analg 1980; 59:323–6.PubMedGoogle Scholar
  144. 144.
    Fewell JE, Abendschein DR, Carlson CJ, Murray JF, Rapaport E. Continuous positive pressure ventilation decreases right and left ventricular end-diastolic volumes in the dog. Circ Res 1980; 46:125–32.PubMedGoogle Scholar
  145. 145.
    Girling L, Ghignone M, Prewitt RM. Effect of increased pulmonary vascular resistance (PVR) and treatment on right ventricular (RV) performance in acute respiratory failure (ARF). Am Rev Respir Dis 1982; 125(Suppl.):99(Abst).Google Scholar
  146. 146.
    Esterly JR, Oppenheimer EH. Some aspects of cardiac pathology in infancy and childhood. IV. Myocardial and coronary lesions in cardiac malformations. Pediatrics 1967; 39:896–903.PubMedGoogle Scholar
  147. 147.
    Franciosis RA, Blanc WA. Myocardial infarcts in infants and children. I. A necropsy study in congenital heart disease. J Pediat 1968; 73:309–19.Google Scholar
  148. 148.
    Tawes RL Jr,Berry CL, Aberdeen E, Graham GR. Myocardial ischemia in infants. Its role in three common congenital cardiac anomalies. Ann Thorac Surg 1969; 8:383–90.PubMedGoogle Scholar
  149. 149.
    Hallidie-Smith KA. Postductal coarctation of aorta causing myocardial ischaemia and heart failure in the first week of life. Arch Dis Child 1972; 47:719–24.PubMedGoogle Scholar
  150. 150.
    Kiechel F III,Blumenthal S, Griffiths SP. The syndrome of papillary muscle infarction and dysfunction in infants. Birth Defects 1972; 8:44–50.Google Scholar
  151. 151.
    Way GL, Pierce JR, Wolfe RR, McGrath R, Wiggins J, Merenstein GB. Brief clinical and laboratory observations. ST depression suggesting subendocardial ischemia in neonates with respiratory distress syndrome and patent ductus arteriosus. J Pediat 1979; 95:609–11.PubMedGoogle Scholar
  152. 152.
    Jedeikin R, Rowe RD, Freedom RM, Olley PM, Gillan JE. Cerebral arteriovenous malformation in neonates. The role of myocardial ischemia. Ped Cardiol 1983; 4:29–35.Google Scholar
  153. 153.
    Petkau D, Kettner JD, Slykerman L, Girling L, Prewitt RM. Volume versus dopamine to maintain cardiac output as right ventricular afterload increases. Can Anaesth Soc J 1983; 30:S69-S70.Google Scholar
  154. 154.
    Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 1984; 60:132–5.PubMedGoogle Scholar
  155. 155.
    Murray JF, Gold P, Johnson BL Jr. The circulatory effects of hematocrit variations in normovolemic and hypervolemic dogs. J Clin Invest 1963; 42:1150–9.PubMedGoogle Scholar
  156. 156.
    Agarwal JB, Paltoo R, Palmer WH. Relative viscosity of blood at varying hematocrits in pulmonary circulation. J Appl Physiol 1970; 29:866–71.PubMedGoogle Scholar
  157. 157.
    Ghignone M, Prewitt RM, Razen M, Girling L, Slykerman L. Effects of increased viscosity on right ventricular function when pulmonary vascular resistance is elevated. Can Anaesth Soc J 1983; 30:S74–5.Google Scholar
  158. 158.
    Miller RR, Vismara LA, Williams DO, Amsterdam EA, Mason DT. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure: differential effects of nitroprusside, phentolamine, and nitroglycerine on cardiac function and peripheral circulation. Circ Res 1976; 39:127–33.PubMedGoogle Scholar
  159. 159.
    Faraci PA. Rheinlander HF, Cleveland RJ. Use of nitroprusside for control of pulmonary hypertension in repair of ventricular septal defect. Ann Thorac Surg 1980; 29:70–3.PubMedGoogle Scholar
  160. 160.
    Rubis LJ, Stephenson LW, Johnston MR, Nagaraj S, Edmunds LH Jr. Comparison of effects of prostaglandin E1 and nitroprusside on pulmonary vascular resistance in children after open-heart surgery. Ann Thorac Surg 1981; 32:563–70.PubMedGoogle Scholar
  161. 161.
    Pearl RC, Rosenthal MH, Schroeder JS, Ashton JPA. Acute hemodynamic effects of nitroglycerin in pulmonary hypertension. Ann Intern Med 1983; 99:9–13.PubMedGoogle Scholar
  162. 162.
    llbawi MN, ldriss FS, DeLeon SY, Berry TE, Paul MH. Hemodynamic effects of intravenous nitroglycerine in postoperative pediatric cardiac patients. Circulation 1984; 70:II-25 (Abstract).Google Scholar
  163. 163.
    Ziskind Z, Pohoryles L, Mohr R, Smolinsky A, Quang HT, Goor DA. Effect of nitroglycerin on pulmonary vascular resistance after mitral valve surgery. Circulation 1984; 70:II-329 (Abstract).Google Scholar
  164. 164.
    Wheller J, George BL, Mulder DG, Jarmakani JM. Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 1979; 60:1640–4.PubMedGoogle Scholar
  165. 165.
    Rabinovitch M, Keane JF, Norwood WI, Castaneda AR, Reid L. Vascular structure in lung tissue obtained at biopsy correlated wtih pulmonary hemodynamic findings after repair of congenital heart defects. Circulation 1984; 69:655–67.PubMedGoogle Scholar
  166. 166.
    Stanger P, Heymann MA, Hoffman JIE, Rudolph AM. Use of the Swan-Ganz catheter in cardiac catheterization of infants and children. Am Heart J 1972; 83:749–54.PubMedGoogle Scholar
  167. 167.
    Pollack MM, Reed TP, Holbrook PR, Fields Al. Bedside pulmonary artery catheterization in pediatrics. J Pediatr 1980; 96:274–6.PubMedGoogle Scholar
  168. 168.
    Hauge A. Hypoxia and pulmonary vascular resistance. The relative effects of pulmonary arterial and alveolar PO2. Acta Physio Scand 1969; 76:121–30.Google Scholar
  169. 169.
    Sylvester JT, Harabin AL, Peake MD, Frank RS. Vasodilator and constrictor responses to hypoxia in isolated pig lungs. J Appl Physio 1980; 49:820–5.Google Scholar
  170. 170.
    Ahmed T, Oliver W Jr. Does slow-reacting substance of anaphylaxis mediate hypoxic pulmonary vasoconstriction? Am Rev Respir Dis 1983; 127:566–71.PubMedGoogle Scholar
  171. 171.
    Reeves JT, Stenmark KR.Voelkel NF. Possible role of leukotrienes in the pathogenesis of pulmonary hypertensive disorders. In: Said SI, ed. The pulmonary circulation and acute lung injury. Mount Kisco, NY: Futura Publishing Co., 1985.Google Scholar
  172. 172.
    Hegyi T, Hiatt lM. Tolazoline and dopamine therapy in neonatal hypoxia and pulmonary vasospasm. Acta Pediatr Scand 1980; 69:101–3.Google Scholar
  173. 173.
    Fox WW, Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 1983; 103:505–14.PubMedGoogle Scholar
  174. 174.
    Shapiro BJ, Simmons DH, Linde LM. Pulmonary hemodynamics during acute acid-base changes in the intact dog. Am J Physiol 1966; 210:1026–32.PubMedGoogle Scholar
  175. 175.
    Malik AB, Kidd BSL. Independent effets of changes in H+ and CO2 concentrations on hypoxic pulmonary vasoconstriction. J Appl Physiol 1973; 34:318–23.PubMedGoogle Scholar
  176. 176.
    Chi TL, Krovetz J. The pulmonary vascular bed in children with Down syndrome. J Pediatr 1975; 86:533–38.Google Scholar
  177. 177.
    Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 1978; 58:1107–22.PubMedGoogle Scholar
  178. 178.
    Wagenvoort CA. Lung biopsy specimens in the evalution of pulmonary vascular disease. Chest 1980; 77:614–25.PubMedGoogle Scholar
  179. 179.
    Hoffman JIE, Rudolph AM, Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 1981; 64:873–7.PubMedGoogle Scholar
  180. 180.
    Yamaki S, Horiuchi T, Sekino Y. Quantitative analysis of pulmonary vascular disease in simple cardiac anomalies with the Down syndrome. Am J Cardiol l983; 51:1502–6.Google Scholar
  181. 181.
    Juaneda EH, aworth S. Pulmonary vascular structure in patients dying after a Fontan procedure. The lung as a risk factor. Br Heart J 1984; 52:575–80.PubMedGoogle Scholar
  182. 182.
    Goldstein JD, Rabinovitch M, Van Praagh R, Reid L. Unusual vascular anomalies causing persistent pulmonary hypertension in a newborn. Am J Cardiol 1979; 43:962–8.PubMedGoogle Scholar
  183. 183.
    Murphy JD, Rabinovitch M, Goldstein JD, Reid LM. The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr 1981 ; 98:962–7.PubMedGoogle Scholar
  184. 184.
    Stenmark KR, James SL, Voelkel NF, Toews WH, Reeves JT, Murphy RC. Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. N Engl J Med 1983; 309:77–80.PubMedGoogle Scholar
  185. 185.
    Ogawa K, Hiroshi I, Toriyama A el al. Lung pathology in infants with severe pulmonary hypertension and cardiac disease. J Thorac Cardiovasc Surg 1979; 77:728–32.PubMedGoogle Scholar
  186. 186.
    Cooney TP.Thurlbeck WM. Pulmonary hypoplasis in Down’s syndrome. N Engl J Med 1982; 307:170–3.Google Scholar
  187. 187.
    Yamaki S, Horiuchi T, Takahashi T. Pulmonary changes in congenital heart disease with Down’s syndrome: their significance as a cause of postoperative respiratory failure. Thorax 1985; 40:380–6.PubMedGoogle Scholar
  188. 188.
    Berry EM, Edmonds JF.Wyllie JH. Release of prostaglandin E2 and unidentified factors from ventilated lungs. Br J Surg 1971; 58:189–92.PubMedGoogle Scholar
  189. 189.
    Said SI. Pulmonary metabolism of prostaglandins and vasoactive peptides. Annu Rev Physiol 1982; 44:257–68.PubMedGoogle Scholar
  190. 190.
    West JB. Respiratory Physiology-The Essentials, 2nd edition. Baltimore: Williams and Wilkins, pp. 33–50, 1979.Google Scholar
  191. 191.
    Jenkins J, Lynn A, Edmonds J, Baker GA. Effects of mechanical ventilation on cardiopulmonary function in children after open-heart surgery. Crit Care Med 1985; 13:77–80.PubMedGoogle Scholar
  192. 192.
    Berend N, Christopher KL, Voelkel NF. Theeffect of positive end-expiratory pressure on functional residual capacity: role of prostaglandin production. Am Rev Respir Dis 1982; 126:646–7.PubMedGoogle Scholar
  193. 193.
    Trichet B, Falke KT, ogut A, Laver MB. The effect of pre-existing pulmonary vascular disease on the response of mechanical ventilation with PEEP following open-heart surgery. Anesthesiology 1975; 42:56–67.PubMedGoogle Scholar
  194. 194.
    Hayman AL, Lippton HL, lgnarro LJ, Wood KS, McNamara DB, Kadwitz PJ. Analysis of autonomic response in the pulmonary vascular bed. In: Said SI, ed. The Pulmonary Circulation and Acute Lung Injury. Mount Kisco, NY: Futura Publishing Co., 1985.Google Scholar
  195. 195.
    Mentzer RM, Alegre CA, Nolan SP. The effects of dopamine and isproterenol on the pulmonary circulation. J Thorac Cardiovasc Surg 1976; 71:807–14.PubMedGoogle Scholar
  196. 196.
    Holloway EL, Polumbo RA, Harrison DC. Acute circulatory effects of dopamine in patients with pulmonary hypertension. Br Heart J 1975; 37:482–5.PubMedGoogle Scholar
  197. 197.
    Stephenson LW, Edmunds LH Jr,Raphaely R, Morrison DF, Hoffman WS, Rubis LJ. Effects of nitroprusside and dopamine on pulmonary arterial vasculature in children after cardiac surgery. Circulation 1979; 60:104–10.PubMedGoogle Scholar
  198. 198.
    Lang P, Williams RG, Norwood WI, Castaneda AR. The hemodynamic effects of dopamine in infants after corrective cardiac surgery. J Pediatr 1980; 96:630–4.PubMedGoogle Scholar
  199. 199.
    Williams DB, Kiernan PD, Schaff HV, Marsh HM, Danielson GK. The hemodynamic response to dopamine and nitroprusside following right atriumpulmonary artery bypass (Fontan procedure). Ann Thorac Surg 1982; 34:51–7.PubMedGoogle Scholar
  200. 200.
    Rubin LJ, Peter RH. Oral hydralazine therapy for primary pulmonary hypertension. N Engl J Med 1980; 302:69–73.PubMedGoogle Scholar
  201. 201.
    Hermiller JB, Bambach D, Thompson MJ et al. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension. Ann Int Med 1982; 97:480–9.PubMedGoogle Scholar
  202. 202.
    Packer M, Greenberg B, Massie B, Dash H. Deleterious effects of hydralazine in patients with pulmonary hypertension. N Engl J Med 1982; 306:1326–31.PubMedGoogle Scholar
  203. 203.
    Brent BN, Berger HJ, Matthay RA, Mahler D, Pytlik L, Zaret BL. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radio-nuclide-hemodynamic study. Am J Cardiol 1983; 51:1682–9.PubMedGoogle Scholar
  204. 204.
    Rich S, Ganz R, Levy PS. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension. Am J Cardiol 1983; 52:1104–7.PubMedGoogle Scholar
  205. 205.
    Rich S, Brundage BH, Levy PS. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Circulation 1985; 71:1191–6.PubMedGoogle Scholar
  206. 206.
    Daoud FS, Reeves JT, Kelly DB. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am J Cardiol 1978; 42:817–22.PubMedGoogle Scholar
  207. 207.
    Lupi-Herrera E, Bialostozky D, Sobrino A. The role of isoproterenol in pulmonary artery hypertension of unknown etiology (primary). Chest 1981; 79:292–6.PubMedGoogle Scholar
  208. 208.
    Pietro DR, LaBresh KA, Shulman RM, Folland ED. Parisi AF, Sasahara AA. Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol. N Engl J Med 1984; 310:1032–4.PubMedGoogle Scholar
  209. 209.
    Rubin LJN, icod P, Hillis LD, Firth BG. Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation. Ann Int Med 1983; 99:433–8.PubMedGoogle Scholar
  210. 210.
    Wood BA, Tortoledo F, Luck JC, Fennell WH. Rapid attenuation of response to nifedipine in primary pulmonary hypertension. Chest 1982; 82:793–4.PubMedGoogle Scholar
  211. 211.
    Weiner N. Drugs that inhibit adrenergic nerves and block adrenergic receptors. In: Gilman AG, Goodman LS, Rail TW, Murad F, eds. The Pharmacological Basis of Therapeutics, 7th edition. Toronto: MacMillan, Inc., 1985.Google Scholar
  212. 212.
    Camerini F, Alberti E, Klungman S, Salvi A. Primary pulmonary hypertension: effects of nifedipine. Br Heart J 1980; 44:352–6.PubMedGoogle Scholar
  213. 213.
    Simonneau G, Escourrou P, Duroux P, Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 1981 ; 304:1582–5.PubMedGoogle Scholar
  214. 214.
    Sturani C, Bassein L, Schiavina M, Gunella G. Oral nifedipine in chronic cor pulmonale secondary to severe chronic obstructive pulmonary disease (COPD). Short and long-term hemodynamic effects. Chest 1983; 84:135–42.PubMedGoogle Scholar
  215. 215.
    Michael JR, Kennedy TP, Fitzpatrick S, Rosenstein BJ. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale. Am Rev RespirDis 1984, 130:516–9.Google Scholar

Copyright information

© Canadian Anesthesiologists 1986

Authors and Affiliations

  • Frederick A. Burrows
    • 1
    • 2
  • John R. Klinck
    • 1
  • Marlene Rabinovitch
    • 1
  • Desmond J. Bohn
    • 1
  1. 1.From the Departments of Anaesthesia and Intensive Care, and the Division of Cardiology (Department of Paediatrics)The Hospital for Sick Children and the University of TorontoToronto
  2. 2.Department of AnaesthesiaThe Hospital for Sick ChildrenToronto

Personalised recommendations